1Kaneda MM, Caruthers S, Lanza GM, et al. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics. Ann Biomed Eng, 2009,37(10):1922-1933.
2Kornmann LM, Curls I)M, Hermeling E, et al. Perfluorohexane- loaded macrophages as a novel ultrasound contrast agent : A feasi- bility study. Mol Imaging Biol, 2008, 10(5):264 270.
3Saha P, Modarai B, Humphries J, et al. The monocyte/macro- phage as a therapeutic target in atherosclerosis. Curr Opin Phar- macol, 2009,9(2) : 109-118.
4Schad KC, Hynynen K: In vitro characterization of perfluorocar- bon droplets for focused ultrasound therapy. P hys Med Biol, 2010,55(17) :4933-4947.
5Diaz-L6pez R, Tsapis N, Fattal E. Liquid perf|uorocarbons as contrast agents for ultrasonography and (19) F-MRI. Pharm Res, 2010,27(1):1-16.
6Ragde H, Kenny GM, Murphy GP, et al. Transrectal ultrasound microbubble contrast angiography of the prostate. Prostate,1997,32 (4) : 279-283.
7Rapoport NY, Efros AL, Christensen DA, et al. Microbubble Generation in Phase-Shift Nanoemulsions used as Anticancer Drug Carriers. Bubble Sci Eng Technol, 2009,1(1-2):31 39.
8Pisani E, Tsapis N, Paris J, et al. Polymeric'nano/microcap- sules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization. Langmuir, 2006,22(9) :4397-4402.
9Kripfgans OD, Fowlkes JB, Miller DL, et al. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultra- sound Med Biol, 2000,26(7) : 1177-1189.
10Rapoport NY, Kennedy AM, Shea JE, et al. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemul- sions/microbubbles. I Control Release. 2009. 138(3) :268-276.
